LMAT
LeMaitre Vascular, Inc. NASDAQ Listed Oct 19, 2006$108.00
Mkt Cap $2.5B
52w Low $78.35
74.8% of range
52w High $118.01
50d MA $110.15
200d MA $93.41
P/E (TTM)
43.9x
EV/EBITDA
22.0x
P/B
6.5x
Debt/Equity
0.5x
ROE
14.7%
P/FCF
24.7x
RSI (14)
—
ATR (14)
—
Beta
0.67
50d MA
$110.15
200d MA
$93.41
Avg Volume
220.9K
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
63 Second Avenue · Burlington, MA 01803 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.66 | 0.68 | +3.0% | 112.00 | +1.5% | -1.6% | -2.1% | — | — | — | — |
| Feb 25, 2026 | AMC | 0.67 | 0.68 | +1.5% | 91.38 | +11.6% | +24.4% | -4.8% | -0.7% | +0.4% | -1.3% | — |
| Nov 6, 2025 | AMC | 0.56 | 0.62 | +9.9% | 85.60 | -3.0% | +1.4% | +1.1% | +2.9% | -0.4% | -0.4% | — |
| Aug 5, 2025 | AMC | 0.57 | 0.60 | +5.3% | 85.60 | +8.7% | +8.9% | +1.1% | -2.1% | +0.4% | +1.9% | — |
| May 1, 2025 | AMC | 0.50 | 0.48 | -4.0% | 90.24 | -2.1% | -12.8% | +2.2% | +2.1% | -0.6% | -0.1% | — |
| Feb 27, 2025 | AMC | 0.49 | 0.49 | +0.0% | 99.91 | -9.9% | -8.1% | +0.3% | -1.8% | -3.8% | -5.2% | — |
| Oct 31, 2024 | AMC | 0.44 | 0.49 | +11.4% | 88.39 | +1.0% | +7.3% | +1.5% | +2.4% | +3.1% | -0.6% | — |
| Aug 1, 2024 | AMC | 0.47 | 0.52 | +10.6% | 86.25 | +4.9% | -1.4% | -5.3% | +1.8% | -1.9% | +3.3% | — |
| May 2, 2024 | AMC | 0.39 | 0.44 | +12.8% | 66.77 | +7.8% | +11.2% | +1.1% | +1.2% | -1.2% | +1.3% | — |
| Feb 27, 2024 | AMC | 0.36 | 0.38 | +5.6% | 62.11 | +4.7% | +14.4% | -1.5% | -3.5% | +0.5% | -0.7% | — |
| Nov 1, 2023 | AMC | 0.30 | 0.33 | +10.0% | 47.82 | +0.0% | -2.4% | +3.9% | +1.5% | +0.5% | -0.1% | — |
| Aug 1, 2023 | AMC | 0.32 | 0.36 | +12.5% | 62.82 | +4.2% | +3.0% | -11.6% | -0.6% | +1.3% | -0.9% | — |
| May 2, 2023 | AMC | 0.25 | 0.27 | +8.0% | 54.75 | +7.8% | +15.2% | +3.4% | +3.6% | -1.4% | -1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | Citizens | Maintains | Market Outperform → Market Outperform | — | $91.38 | $102.00 | +11.6% | +24.4% | -4.8% | -0.7% | +0.4% | -1.3% |
| Feb 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.38 | $102.00 | +11.6% | +24.4% | -4.8% | -0.7% | +0.4% | -1.3% |
| Feb 26 | Roth Capital | Maintains | Buy → Buy | — | $91.38 | $102.00 | +11.6% | +24.4% | -4.8% | -0.7% | +0.4% | -1.3% |
| Feb 26 | Barrington Research | Maintains | Outperform → Outperform | — | $91.38 | $102.00 | +11.6% | +24.4% | -4.8% | -0.7% | +0.4% | -1.3% |
| Feb 20 | Barrington Research | Maintains | Outperform → Outperform | — | $91.86 | $92.25 | +0.4% | +1.2% | -1.7% | -0.7% | +0.7% | +24.4% |
| Nov 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $85.60 | $83.03 | -3.0% | +1.4% | +1.1% | +2.9% | -0.4% | -0.4% |
| Oct 15 | Barrington Research | Maintains | Outperform → Outperform | — | $87.38 | $87.12 | -0.3% | -0.1% | -0.5% | -0.3% | +1.6% | +2.0% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $92.29 | $92.29 | +0.0% | -2.6% | -2.3% | -3.6% | -0.6% | +1.5% |
| Aug 6 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $85.60 | $93.03 | +8.7% | +8.9% | +1.1% | -2.1% | +0.4% | +1.9% |
| Aug 6 | Barrington Research | Upgrade | Market Perform → Outperform | — | $85.60 | $93.03 | +8.7% | +8.9% | +1.1% | -2.1% | +0.4% | +1.9% |
| Jul 22 | Barrington Research | Maintains | Market Perform → Market Perform | — | $79.82 | $80.24 | +0.5% | +0.7% | +2.2% | -1.7% | +2.1% | +0.0% |
| Feb 28 | Lake Street | Maintains | Buy → Buy | — | $99.91 | $90.00 | -9.9% | -8.1% | +0.3% | -1.8% | -3.8% | -5.2% |
| Feb 28 | Citizens Capital Markets | Maintains | Buy → Buy | — | $99.91 | $90.00 | -9.9% | -8.1% | +0.3% | -1.8% | -3.8% | -5.2% |
| Feb 28 | Barrington Research | Downgrade | Outperform → Market Perform | — | $99.91 | $90.00 | -9.9% | -8.1% | +0.3% | -1.8% | -3.8% | -5.2% |
| Nov 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $88.39 | $89.25 | +1.0% | +7.3% | +1.5% | +2.4% | +3.1% | -0.6% |
| Nov 1 | Barrington Research | Maintains | Outperform → Outperform | — | $88.39 | $89.25 | +1.0% | +7.3% | +1.5% | +2.4% | +3.1% | -0.6% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $90.18 | $90.18 | +0.0% | -0.2% | +1.6% | -0.3% | -2.1% | +1.2% |
| Aug 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $85.53 | $86.34 | +0.9% | -0.2% | +1.3% | -0.4% | +6.4% | -1.0% |
| Aug 2 | Barrington Research | Maintains | Outperform → Outperform | — | $86.25 | $90.50 | +4.9% | -1.4% | -5.3% | +1.8% | -1.9% | +3.3% |
| May 3 | Barrington Research | Maintains | Outperform → Outperform | — | $66.77 | $72.00 | +7.8% | +11.2% | +1.1% | +1.2% | -1.2% | +1.3% |
| May 3 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $66.77 | $72.00 | +7.8% | +11.2% | +1.1% | +1.2% | -1.2% | +1.3% |
| Apr 26 | Stifel | Upgrade | Hold → Buy | — | $62.99 | $65.34 | +3.7% | +3.9% | +1.2% | -2.2% | +3.1% | -0.0% |
| Feb 28 | Barrington Research | Maintains | Outperform → Outperform | — | $62.11 | $65.00 | +4.7% | +14.4% | -1.5% | -3.5% | +0.5% | -0.7% |
| Aug 3 | Jefferies | Downgrade | Buy → Hold | — | $64.70 | $63.34 | -2.1% | -11.6% | -0.6% | +1.3% | -0.9% | -0.1% |
| Aug 2 | Lake Street | Maintains | Buy → Buy | — | $62.82 | $65.47 | +4.2% | +3.0% | -11.6% | -0.6% | +1.3% | -0.9% |
| Aug 2 | Barrington Research | Maintains | Outperform → Outperform | — | $62.82 | $65.47 | +4.2% | +3.0% | -11.6% | -0.6% | +1.3% | -0.9% |
| May 3 | Barrington Research | Upgrade | Market Perform → Outperform | — | $54.75 | $59.00 | +7.8% | +15.2% | +3.4% | +3.6% | -1.4% | -1.7% |
| Oct 28 | Barrington Research | Downgrade | Outperform → Market Perform | — | $51.83 | $46.65 | -10.0% | -19.1% | +3.5% | -0.7% | +1.9% | +1.4% |
| Sep 16 | Jefferies | Maintains | Buy → Buy | — | $57.48 | $58.38 | +1.6% | +1.2% | -2.4% | -2.8% | -2.0% | +2.1% |
| Aug 3 | Roth Capital | Maintains | Neutral → Neutral | — | $54.71 | $54.72 | +0.0% | +2.3% | -1.2% | +2.7% | +1.8% | -1.1% |
| May 4 | Roth Capital | Maintains | Neutral → Neutral | — | $51.46 | $51.01 | -0.9% | -0.3% | +1.1% | -1.5% | -0.4% | -4.4% |
| Feb 12 | KeyBanc | Maintains | Sector Weight → Equal Weight | — | $47.53 | $47.62 | +0.2% | +3.4% | -1.2% | -0.5% | +0.3% | +1.5% |
| Oct 30 | Roth Capital | Maintains | Neutral → Neutral | — | $35.54 | $35.60 | +0.2% | -8.6% | +4.6% | +2.7% | -1.3% | +0.6% |
| Jul 24 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.93 | $31.99 | +10.6% | +10.3% | -6.0% | -1.9% | +3.1% | -0.2% |
| Jul 24 | Stifel | Maintains | Hold → Hold | — | $28.93 | $31.99 | +10.6% | +10.3% | -6.0% | -1.9% | +3.1% | -0.2% |
| May 4 | Stifel | Maintains | Hold → Hold | — | $26.37 | $25.83 | -2.0% | -4.1% | +3.4% | -0.1% | +0.5% | +0.6% |
| Apr 14 | Canaccord Genuity | Maintains | Hold → Hold | — | $26.94 | $27.38 | +1.6% | +3.8% | -3.9% | +3.5% | +6.1% | -5.6% |
| Apr 8 | Sidoti & Co. | Maintains | Buy → Buy | — | $24.73 | $25.22 | +2.0% | +4.4% | +6.4% | -1.9% | +3.8% | -3.9% |
| Mar 16 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $24.45 | $23.76 | -2.8% | -9.7% | +14.9% | -1.1% | -5.6% | -9.7% |
| Oct 24 | First Analysis | Downgrade | Strong Buy → Outperform | — | $36.00 | $37.01 | +2.8% | -4.5% | +1.7% | +0.7% | +1.4% | +0.2% |
| Oct 24 | Lake Street | Upgrade | Hold → Buy | — | $36.00 | $37.01 | +2.8% | -4.5% | +1.7% | +0.7% | +1.4% | +0.2% |
| Oct 14 | First Analysis | Upgrade | Outperform → Strong Buy | — | $31.33 | $32.27 | +3.0% | +3.4% | +4.2% | +0.5% | +2.3% | +1.0% |
| Jul 25 | First Analysis | Upgrade | Neutral → Outperform | — | $33.40 | $34.40 | +3.0% | -1.9% | -0.5% | +0.6% | -0.5% | +1.3% |
| Oct 8 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.53 | $29.04 | +1.8% | -0.4% | -6.2% | +2.5% | +2.3% | +1.0% |
| Oct 8 | Roth Capital | Maintains | Buy → Buy | — | $28.53 | $29.04 | +1.8% | -0.4% | -6.2% | +2.5% | +2.3% | +1.0% |
| Jul 9 | Canaccord Genuity | Maintains | Hold → Hold | — | $36.73 | $36.96 | +0.6% | -2.0% | +0.7% | +0.5% | +0.3% | -0.0% |
| Jun 25 | Lake Street | Maintains | Buy → Buy | — | $35.18 | $35.62 | +1.3% | +0.0% | +2.2% | -4.2% | -2.0% | -0.7% |
| Apr 26 | Stifel | Downgrade | Buy → Hold | — | $39.01 | $35.88 | -8.0% | -17.1% | -2.7% | -0.1% | +4.0% | +2.2% |
| Apr 26 | Stifel Nicolaus | Downgrade | Buy → Hold | — | $39.01 | $35.88 | -8.0% | -17.1% | -2.7% | -0.1% | +4.0% | +2.2% |
| Apr 26 | Benchmark | Upgrade | Hold → Buy | — | $39.01 | $35.88 | -8.0% | -17.1% | -2.7% | -0.1% | +4.0% | +2.2% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The board reduction from eight to seven members and planned executive transition suggest potential leadership restructuring at LendingMarket, which investors should monitor for implications on strategic direction and management continuity.
Apr 14
8-K
LeMaitre Vascular, Inc. -- 8-K Filing
LeMaitre Vascular filed standard forward-looking statement disclaimers and exhibits documentation with the SEC, providing no material updates to investor expectations regarding the vascular medical device company's operations or financial performance.
Feb 25
Data updated apr 25, 2026 7:24pm
· Source: massive.com